Detection of SARS-CoV-2 variants by Abbott molecular, antigen, and serological tests
2022; Elsevier BV; Volume: 147; Linguagem: Inglês
10.1016/j.jcv.2022.105080
ISSN1873-5967
AutoresMary A. Rodgers, Alessandro Olivo, Barbara J. Harris, Chris Lark, Xinxin Luo, Michael G. Berg, Todd Meyer, Aurash Mohaimani, Gregory S. Orf, D. Goldstein, Amy S. Fox, Julie Hirschhorn, W. Bailey Glen, Frederick S. Nolte, Alan Landay, Cheryl Jennings, James N. Moy, Venice Servellita, Charles Y. Chiu, Rahul Batra, Luke B. Snell, Gaia Nebbia, Sam Douthwaite, Amílcar Tanuri, Lavanya Singh, Túlio de Oliveira, Ambroise D. Ahouidi, Souleymane Mboup, Gavin Cloherty,
Tópico(s)Biosensors and Analytical Detection
ResumoViral diversity presents an ongoing challenge for diagnostic tests, which need to accurately detect all circulating variants. The Abbott Global Surveillance program monitors severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) variants and their impact on diagnostic test performance.
Referência(s)